David Ben Naim
2017
In 2017, David Ben Naim earned a total compensation of $66.2K as Chief Financial Officer at StemCells, a 1,003% increase compared to previous year.
Compensation breakdown
| Option Awards | $188 |
|---|---|
| Salary | $66,000 |
| Total | $66,188 |
Naim received $66K in salary, accounting for 100% of the total pay in 2017.
Naim also received $188 in option awards.
Rankings
In 2017, David Ben Naim's compensation ranked 14,500th out of 14,666 executives tracked by ExecPay. In other words, Naim earned more than 1.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 14,500 out of 14,666 | 1st |
Division Manufacturing | 5,704 out of 5,772 | 1st |
Major group Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks | 851 out of 859 | 1st |
Industry group Surgical, Medical, And Dental Instruments And Supplies | 525 out of 531 | 1st |
Industry Surgical and Medical Instruments and Apparatus | 331 out of 336 | 2nd |
Source: SEC filing on July 26, 2018.
Naim's colleagues
We found two more compensation records of executives who worked with David Ben Naim at StemCells in 2017.